semaglutide and creatinine in patients with overweight or obesity chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial NEVER Mix THIS With Creatine

- Mt N Dng Trng Da Chuyn Su Sur

OASIS 2: A 68-week efficacy and safety phase 3a trial comparing once-daily oral semaglutide (50 mg) to placebo for weight loss in 198 East Asian (including Japanese) adults with obesity or overweight with one or more comorbidities

NAD is a molecule found in every cell of your body that plays a key role in turning food into fuel

Prioritise omega-3-rich foods like oily fish, protein sources containing tryptophan (turkey, eggs, salmon), and fibre-rich foods that support gut health

Skip berberine

The global thrombopoietin receptor agonists market was estimated at US$ 1.85 billion in 2023 and is projected to grow to US$ 3.74 billion by 2034, rising at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2034